The Evidence Gap: Immunotherapy Timing in Early-Stage NSCLC?January 6, 2025Lung CancerPatient & Survivor CareImmunotherapyImmuno-oncology
The Protein Problem: The Unsolved Mystery of AI Drug DevDecember 19, 2024Immuno-oncologyLung CancerBreast Cancer
Intratumoral Dendritic Cell Therapy Shows Promise in Early-Stage ERBB2-Positive Breast CancerDecember 9, 2024Breast CancerImmuno-oncologyImmunotherapyPatient & Survivor Care
New Cancer Vaccines on the Horizon: Renewed Hope or Hype?December 6, 2024Preventive CarePatient & Survivor CareImmunotherapyImmuno-oncologyMixed TopicsGynecologic CancerGenitourinary Cancer
Outpatient CAR T: Safe, Effective, AccessibleNovember 4, 2024Immuno-oncologyImmunotherapyLeukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMixed TopicsPractice ManagementPatient & Survivor Care
Risk Assessment Tool Can Help Predict Fractures in CancerOctober 21, 2024Patient & Survivor CareBreast CancerCNS/Brain CancerFollicular LymphomaGastroenterologyGastrointestinal CancerGenitourinary Cancer
Many Hurdles Exist to Treating Lung Cancer With CAR T CellsOctober 10, 2024Lung CancerImmunotherapyImmuno-oncologyPatient & Survivor CarePractice Management
A Simple Blood Test May Predict Cancer Risk in T2DSeptember 11, 2024Preventive CareBreast CancerGastrointestinal CancerPatient & Survivor CareMetastatic Breast CancerImmuno-oncologyGynecologic Cancer
Cancer Treatment 101: A Primer for Non-OncologistsAugust 23, 2024Breast CancerCNS/Brain CancerDLBCLFollicular LymphomaGastroenterologyGastrointestinal CancerImmunotherapy
Diagnosing, Treating Rashes In Patients on Immune Checkpoint InhibitorsAugust 21, 2024MelanomaMixed TopicsImmunotherapyImmuno-oncology
Jeffrey Weber, MD, PhD, Giant of Cancer Care, DiesAugust 21, 2024Mixed TopicsMelanomaImmunotherapyImmuno-oncologyPractice Management
Immunotherapy and Survival in Advanced NSCLC: Does Obesity Matter?August 12, 2024Lung CancerPatient & Survivor CareImmunotherapyImmuno-oncology
FDA Approves Lymphir for R/R Cutaneous T-Cell LymphomaAugust 9, 2024Patient & Survivor CareImmunotherapyLymphoma & Plasma Cell DisordersImmuno-oncologyPractice Management
Immunotherapy May Be Overused in Dying Patients With CancerAugust 8, 2024ImmunotherapyImmuno-oncologyBreast CancerCNS/Brain CancerDLBCLFollicular LymphomaGastroenterology
Modest Gains Shown in Breast Cancer Immunotherapy TrialsAugust 8, 2024Breast CancerMetastatic Breast CancerPatient & Survivor CareImmunotherapyImmuno-oncology
